A Prospective, Pre-ecLampsia/Eclampsia Prevention IntervEntio
Phase 3
Withdrawn
- Conditions
- PreeclampsiaPregnancyReproductive Health and Childbirth - Antenatal careCardiovascular - Hypertension
- Registration Number
- ACTRN12618000690257
- Lead Sponsor
- niversity of Melbourne (through its Department of Obstetrics and Gynaecology)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Female
- Target Recruitment
- 5500
Inclusion Criteria
•Nulliparous
•BMI of =>30 kg/m² at hospital booking visit
•12 - 20 weeks of pregnancy at the time of recruitment
•Singleton pregnancy
•Age 18 and above
•Able to comprehend study information
Exclusion Criteria
•Patient is unable or unwilling to give consent
•Known/suspected major fetal malformation or infection
•Any current use of a PPI
•Contraindications to the use of esomeprazole
•Pre-existing renal impairment
•Pre-existing hepatic impairment
•HIV, Hepatitis B, or Hepatitis C positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method